In 2016, scientists in Japan announced they had successfully grown human skin in a lab. The skin was created using induced pluripotent stem cells, and when implanted in a mouse, the skin grew hairs successfully. Dr. Takashi Tsuji has sought donations for the group's research. The group has also formed a partnership with Organ Technologies and Kyocera Corporation to commercially develop the research. Organ Technologies secured funding from Kobayashi Pharmaceutical in late 2022 and was renamed to OrganTech in 2023. OrganTech hopes to transplant both regenerated hair follicle primordia and what they term "next-generation implants" into humans as soon as Q2 2024.